|
69
|
300
|
4pdsA |
Crystal structure of rad53 kinase domain and scd2 in complex with amppnp |
|
93
|
290
|
4py1A |
Crystal structure of tyk2 in complex with compound 15, 6-((2,5-dimethoxyphenyl)thio)-3-(1-methyl-1h-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine |
|
89
|
346
|
4ptcA |
Structure of a carboxamide compound (3) (2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to gsk3b |
|
85
|
291
|
4pmtA |
The structure of trka kinase bound to the inhibitor n~4~-(4-morpholin-4-ylphenyl)-n~6~-(pyridin-3-ylmethyl)pyrido[3,2-d]pyrimidine-4,6-diamine |
|
53
|
169
|
4q5hA |
Shigella effector kinase ospg bound to amppnp and e2-ub ubch7-ub conjugate |
|
86
|
281
|
4ow8A |
Crystal structure of kinase domain of pkna from mtb |
|
164
|
504
|
4pniA |
Bovine g protein-coupled receptor kinase 1 in complex with gsk2163632a |
|
70
|
274
|
4pwnA |
Crystal structure of active wnk1 kinase |
|
67
|
264
|
4ppbA |
Itk kinase domain with compound 28 (n-{1-[(1s)-3-(dimethylamino)-1-phenylpropyl]-1h-pyrazol-4-yl}-6-(1h-pyrazol-4-yl)-1h-indazole-3-carboxamide) |
|
94
|
291
|
4pmmA |
The structure of trka kinase bound to the inhibitor n-(3-cyclopropyl-1-phenyl-1h-pyrazol-5-yl)-2-{4-[3-methoxy-4-(4-methyl-1h-imidazol-1-yl)phenyl]-1h-1,2,3-triazol-1-yl}acetamide |
|
89
|
290
|
4p7eA |
Triazolopyridine compounds as selective jak1 inhibitors: from hit identification to glpg0634 |
|
152
|
465
|
4onaA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1517 |
|
99
|
347
|
4ptgA |
Structure of a carboxamine compound (26) (2-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide) to gsk3b |
|
96
|
309
|
4nw5A |
Rsk2 n-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 8 |
|
107
|
379
|
4nm3A |
Crystal structure of gsk-3/axin complex bound to phosphorylated n-terminal auto-inhibitory ps9 peptide |
|
88
|
291
|
4njdA |
Structure of p21-activated kinase 4 with a novel inhibitor ky-04031 |
|
111
|
336
|
4o21A |
Product complex of metal-free pkac, atp-gamma-s and sp20. |
|
92
|
293
|
4nfmA |
Human tau tubulin kinase 1 (ttbk1) |
|
72
|
266
|
4o0sA |
Crystal structures of human kinase aurora a |
|
103
|
349
|
4n4sA |
A double mutant rat erk2 in complex with a pyrazolo[3,4-d]pyrimidine inhibitor |
|
72
|
266
|
4o0uA |
Crystal structures of human kinase aurora a |
|
97
|
309
|
4nw6A |
Rsk2 n-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27 |
|
106
|
378
|
4nu1A |
Crystal structure of a transition state mimic of the gsk-3/axin complex bound to phosphorylated n-terminal auto-inhibitory ps9 peptide |
|
87
|
277
|
4o2pA |
Kinase domain of csrc in complex with a substituted pyrazolopyrimidine |
|
104
|
360
|
4nm7A |
Crystal structure of gsk-3/axin complex bound to phosphorylated wnt receptor lrp6 e-motif |
|
81
|
295
|
4oboA |
Map4k4 in complex with inhibitor (compound 22), 6-(3-chlorophenyl)quinazolin-4-amine |
|
94
|
291
|
4o0xA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
70
|
281
|
4o27B |
Crystal structure of mst3-mo25 complex with wif motif |
|
91
|
265
|
4ot6A |
Crystal structure of btk kinase domain complexed with 4-methanesulfonyl-n-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide |
|
88
|
291
|
4o0vA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
88
|
263
|
4otfA |
Crystal structure of the kinase domain of bruton's tyrosine kinase with gdc0834 |
|
87
|
307
|
4nusA |
Rsk2 n-terminal kinase in complex with ljh685 |
|
84
|
323
|
4ogrA |
Crystal structure of p-tefb complex with aff4 and tat |
|
105
|
345
|
4o6eA |
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of erk2 |
|
100
|
293
|
4nfnA |
Human tau tubulin kinase 1 (ttbk1) complexed with 3-({5-[(4-amino-4-methylpiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-bromophenol |
|
96
|
291
|
4o0yA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
89
|
308
|
4neuA |
X-ray structure of receptor interacting protein 1 (rip1)kinase domain with a 1-aminoisoquinoline inhibitor |
|
97
|
365
|
4o2zA |
Crystal structure of mpk3 from leishmania donovani, ldbpk_100540 in the presence of nvp-bbt594 |
|
78
|
274
|
4n6yA |
Pim1 complexed with a phenylcarboxamide |
|
87
|
335
|
4othA |
Crystal structure of prk1 catalytic domain in complex with ro-31-8220 |
|
85
|
263
|
4nwmA |
Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with bms-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide |
|
88
|
324
|
4or5A |
Crystal structure of hiv-1 tat complexed with human p-tefb and aff4 |
|
87
|
298
|
4obpA |
Map4k4 in complex with inhibitor (compound 29), 6-(2-fluoropyridin-4-yl)pyrido[3,2-d]pyrimidin-4-amine |
|
98
|
316
|
4nifA |
Heterodimeric structure of erk2 and rsk1 |
|
78
|
241
|
4o4cA |
Crystal structure of an inositol hexakisphosphate kinase apo-ehip6ka |
|
74
|
267
|
4o0wA |
Crystal structures of human kinase aurora a |
|
88
|
336
|
4otgA |
Crystal structure of prk1 catalytic domain in complex with lestaurtinib |
|
79
|
341
|
4nttA |
Structure of the catalytic subunit of camp-dependent protein kinase bound to adp and one magnesium ion |
|
94
|
263
|
4otrA |
Crystal structure of btk kinase domain complexed with 6-cyclopropyl-2-[3-[5-[[5-(4-ethylpiperazin-1-yl)-2-pyridyl]amino]-1-methyl-6-oxo-3-pyridyl]-2-(hydroxymethyl)phenyl]-8-fluoro-isoquinolin-1-one |
|
76
|
248
|
4o4fA |
Crystal structure of an inositol hexakisphosphate kinase ehip6ka in complexed with atp and insp6 |
